James Hassard Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
James Hassard is Chief Commercial Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 29,259 shares of CRNX, which is worth approximately $1.64 Million. The most recent transaction as insider was on Jul 05, 2024, when has been sold 15,000 shares (Common Stock) at a price of $44.08 per share, resulting in proceeds of $661,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
29.3K
0%
3M change
108.99%
12M change
Total Value Held
$1.64 Million
James Hassard Transaction History
Also insider at
JH
James Hassard
Chief Commercial Officer
San Diego, CA